The potential prognostic utility of salivary galectin-3 concentrations in heart failure

Zhang, X., et al. (2020). "The potential prognostic utility of salivary galectin-3 concentrations in heart failure." Clinical Research in Cardiology 109(6): 685-692.

Background Patients with HF are at a higher risk of rehospitalisation and, as such, significant costs to our healthcare system. A non-invasive method to collect body fluids and measure Gal-3 could improve the current management of HF. In this study, we investigated the potential prognostic utility of salivary Galectin-3 (Gal-3) in patients with heart failure (HF).

Previous
Previous

Pyroglutamic acidosis in a renal …

Next
Next

Anti-thrombogenic Surface Coatings for …